Snowden Capital Advisors LLC Seagen Inc. Transaction History

Snowden Capital Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $12,947 - $14,231	-69 Reduced 3.57%	1,862 $358,000
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $25,007 - $39,803	-196 Reduced 9.21%	1,931 $390,000
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $13,145 - $15,587	112 Added 5.56%	2,127 $273,000
Q3 2022 Nov 09, 2022	SELL	$135.27 - $180.11 $19,478 - $25,935	-144 Reduced 6.67%	2,015 $275,000
Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $1,523 - $2,510	-14 Reduced 0.64%	2,159 $382,000

Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $243,406 - $321,224	2,035 Added 1474.64%	2,173 $313,000
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $19,674 - $26,338	138 New	138 $21,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.